Spisak lijekova koji imaju dozvolu za stavljanje u promet u Bosni i ...

More documents

Recommendations

Info

ATC Naziv lijek Proizvođač INN Oblik Jačina Pakovanje Broj Datum Važi do Postupak C09CA07 ACTELSAR Actavis Group PTC ehf telmisartan tableta 80 mg 28 tableta (2 blistera po 14 tableta) 04-07.1-7009/11 17.7.2012 16.7.2017 Prva registracija C09CA07 MICARDIS BOEHRINGER INGELHEIM telmisartan tableta 40 mg 28 tableta (4 04-07.2-6305/11 18.1.2012 14.2.2017 Obnova registracije RCV GmbH & Co.KG blistera po 7 tableta) C09CA07 MICARDIS BOEHRINGER INGELHEIM telmisartan tableta 80 mg 28 tableta (4 04-07.2-6302/11 18.1.2012 14.2.2017 Obnova registracije RCV GmbH & Co.KG blistera po 7 tableta) C09CA07 PRITOR 40 BAYER SCHERING PHARMA telmisartan tablete 40 mg 28 tableta (4 6.3.2013 AG blistera po 7 tableta) C09CA07 PRITOR 80 BAYER SCHERING PHARMA telmisartan tablete 80 mg 28 tableta (4 6.3.2013 AG blistera po 7 tableta) Obnova registracije Obnova registracije C09CA07 TOLURA KRKA, tovarna zdravil, d.d. telmisartan tablete 20 mg 28 tableta (4 blistera po 7 tableta) 04-07.1-198-48/10 18.4.2011 17.4.2016 Prva registracija C09CA07 TOLURA KRKA, tovarna zdravil, d.d. telmisartan tablete 40 mg 28 tableta (4 blistera po 7 tableta) 04-07.1-198-49/10 18.4.2011 17.4.2016 Prva registracija C09CA07 TOLURA KRKA, tovarna zdravil, d.d. telmisartan tablete 80 mg 28 tableta (4 blistera po 7 tableta) 04-07.1-198-50/10 18.4.2011 17.4.2016 Prva registracija C09CA08 MENARTAN BERLIN-CHEMIE AG olmesartan medoksomil film tableta 40 mg 28 film tableta (2 04-07.2-3787/12 6.12.2017 Obnova registracije (Menarini Group) blistera po 14 tableta) C09CA08 MENARTAN BERLIN-CHEMIE AG olmesartan medoksomil film tableta 20 mg 28 film tableta (2 04-07.2-3788/12 6.12.2017 Obnova registracije (Menarini Group) blistera po 14 tableta) C09CA08 MENARTAN BERLIN-CHEMIE AG olmesartan medoksomil film tableta 10 mg 28 film tablete (2 04-07.2-3786/112 6.12.2017 Obnova registracije (Menarini Group) blistera po 14 tableta) C09DA01 CO-HILOS NOBEL ILAC SANAYII VE losartan, film tablete 50 mg + 12,5 mg 28 film-tableta 04-07.9-370-11/09 7.7.2009 4.7.2013 Potvrda TICARET A.S. hidrohlorotiazid C09DA01 CO-HILOS FORT NOBEL ILAC SANAYII VE losartan, film tablete 100 mg + 25 mg 28 film-tableta 04-07.9-370-12/09 7.7.2009 4.7.2013 Potvrda TICARET A.S. hidrohlorotiazid C09DA01 GALOSART PLUS GALENIKA a.d. losartan, film tableta 50 mg + 12,5 mg 30 film tableta (3 04-07.1-1727-3/10 4.11.2011 3.11.2016 Prva registracija hidrohlorotiazid blistera po 10 tableta) Strana 116. od 331
ATC Naziv lijek Proizvođač INN Oblik Jačina Pakovanje Broj Datum Važi do Postupak C09DA01 LORISTA H KRKA, tovarna zdravil, d.d. losartan, filmom obložena hidrohlorotiazid tableta C09DA01 LORISTA H 100 KRKA, tovarna zdravil, d.d. losartan, filmom obložena hidrohlorotiazid tableta C09DA01 LORISTA HD KRKA, tovarna zdravil, d.d. losartan, filmom obložena hidrohlorotiazid tableta C09DA01 LOSARTAN H Genera GENERA LIJEKOVI d.o.o. losartan, filmom obložena hidrohlorotiazid tableta C09DA01 LOSARTIC PLUS PLIVA HRVATSKA d.o.o. losartan, filmom obložena hidrohlorotiazid tableta 50,0 mg + 12,5 mg 28 filmom obloženih tableta (2 blistera po 14 tableta) 100,0 mg + 12,5 mg 28 filmom obložene tablete (2 blistera po 14 tableta) 100 mg + 25 mg 28 filmom obloženih tableta (2 blistera po 14 tableta) 50,0 mg + 12,5 mg 28 filmom obloženih tableta (2 blistera po 14 tableta) 50,0 mg + 12,5 mg 28 filmom obloženih tableta (2 blistera po 14 tableta) 04-07.2-8817/11 24.5.2012 16.5.2017 Obnova registracije 04-07.1-198-62/10 Prva registracija 04-07.2-8818/11 24.5.2012 16.5.2017 Obnova registracije 04-07.1-7032/11 30.4.2012 29.4.2017 Prva registracija 04-07.2-610-26/10 27.6.2011 9.6.2016 Obnova registracije C09DA01 TENLOP H BOSNALIJEK d.d. losartan, film tableta 100 mg + 25 mg 30 film tableta (3 04-07.2-6468/11 19.1.2012 12.3.2017 Obnova registracije hidrohlorotiazid blistera po 10 tableta) C09DA01 TENLOP H BOSNALIJEK d.d. losartan, film tableta 50 mg + 12,5 mg 30 film tableta (3 04-07.2-6461/11 19.1.2012 12.3.2017 Obnova registracije hidrohlorotiazid blistera po 10 tableta) C09DA03 ATENZIO PLUS ZADA Pharmaceuticals d.o.o. valsartan, film tableta 160 mg+12,5 mg 30 film tableta (3 04-07.1-3108/11 16.1.2012 15.1.2017 Prva registracija hidrohlorotiazid blistera po 10 tableta) C09DA03 ATENZIO PLUS ZADA Pharmaceuticals d.o.o. valsartan, film tableta 80 mg+12,5 mg 30 film tableta (3 04-07.1-3107/11 16.1.2012 15.1.2017 Prva registracija hidrohlorotiazid blistera po 10 tableta) C09DA03 ATENZIO PLUS ZADA Pharmaceuticals d.o.o. valsartan, film tableta 160 mg+25 mg 30 film tableta (3 04-07.1-3109/11 16.1.2012 15.1.2017 Prva registracija hidrohlorotiazid blistera po 10 tableta) C09DA03 CO-DIOVAN NOVARTIS PHARMA Services valsartan, film tablete 80 mg + 12,5 mg 28 film tableta (2 8.7.2013 AG hidrohlorotiazid PVC/PVDC blistera po 14 tableta) C09DA03 CO-DIOVAN NOVARTIS PHARMA Services valsartan, film tablete 160 mg + 12,5 mg 28 film tableta (2 8.7.2013 AG hidrohlorotiazid PVC/PVDC blistea po 14 tableta) Strana 117. od 331 Obnova registracije Obnova registracije
Page 1 and 2:
Spisak lijekova koji imaju dozvolu
Page 3 and 4:
ATC Naziv lijek Proizvođač INN Ob
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66: ATC Naziv lijek Proizvođač INN Ob
Page 115: ATC Naziv lijek Proizvođač INN Ob
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
Page 265 and 266:
Page 267 and 268:
Page 269 and 270:
Page 271 and 272:
Page 273 and 274:
Page 275 and 276:
Page 277 and 278:
Page 279 and 280:
Page 281 and 282:
Page 283 and 284:
Page 285 and 286:
Page 287 and 288:
Page 289 and 290:
Page 291 and 292:
Page 293 and 294:
Page 295 and 296:
Page 297 and 298:
Page 299 and 300:
Page 301 and 302:
Page 303 and 304:
Page 305 and 306:
Page 307 and 308:
Page 309 and 310:
Page 311 and 312:
Page 313 and 314:
Page 315 and 316:
Page 317 and 318:
Page 319 and 320:
Page 321 and 322:
Page 323 and 324:
Page 325 and 326:
Page 327 and 328:
Page 329 and 330:
Page 331:
show all

Spisak lijekova koji imaju dozvolu za stavljanje u promet u Bosni i ...

Create successful ePaper yourself

Delete template?

Save as template?